Stockreport

ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF Roche 's RHHBY Rituxan (rituximab) and Bristol Myers ' BMY Revlimid (lenalidomide) (R ), to treat indolent and aggressive relapsed or refractory B-cell non-Hodgkin lymph [Read more]